General Archives - Page 52 of 2367

2 minute read

‘This Is What We Really Needed’: NYSE Trader Reacts To Inflation Data And Its Impact On Stock Market

May 31, 2:41 PM

Inflation report meets expectations but market still trading lower. Expert says breather needed. Tech stocks down, energy and financial stocks up.

MSFT

2 minute read

Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile

By Vandana Singh

May 31, 2:25 PM

Discover the results of Ionis Pharmaceuticals' Phase 3 studies on donidalorsen for hereditary angioedema. FDA application submission expected this year.

IONS

2 minute read

Nordstrom Brands Don’t Subscribe To ‘Department Stores Are Dead’ Mantra: Analyst Explains Why

By Nabaparna Bhattacharya

May 31, 2:23 PM

Nordstrom is clearly challenged, with historically choppy gross margins, coupled with Rack's relative underperformance among the off-prices.

JWN

2 minute read

FDA Expands Approval For Bristol Myers Squibb’s Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies

By Vandana Singh

May 31, 2:14 PM

FDA approves Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) for relapsed or refractory mantle cell lymphoma, marking its fourth non-Hodgkin lymphoma subtype indication.

BMY

2 minute read

Novartis Sues to Block Maryland’s New Drug Discount Law

By Vandana Singh

May 31, 2:12 PM

Novartis has filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs through third-party pharmacies contracting with hospitals and clinics.

NVS

2 minute read

Best Buy To Stabilize Despite A Soft Q1, Analysts Say

By Shivani Kumaresan

May 31, 2:10 PM

Goldman Sachs analyst Kate McShane noted BBY reported better-than-expected Q1 results and provided guidance that still suggests a potential top-line recovery in the second half of the year.

BBY

2 minute read

Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes

By Vandana Singh

May 31, 2:08 PM

Novo Nordisk has filed lawsuits against nine additional U.S. medical spas, wellness clinics, and pharmacies for selling impure or falsely labeled semaglutide products.

LLY

2 minute read

Pfizer Highlights ‘Unprecedented’ 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer

By Vandana Singh

May 31, 2:02 PM

Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.

PFE

2 minute read

Cautious Optimism Surrounds Dollar General’s FY24: Analysts Highlight Strategic Gains Amid Emerging Risks

By Shivani Kumaresan

May 31, 1:53 PM

Truist Securities has reiterated its Hold rating for Dollar General, lowering the price target from $140 to $135. Analyst Scot Ciccarelli notes better-than-expected comparable sales but expects a backend-loaded year, adjusting 2024/2025 estimates to $7.30/$8.05 from $7.35/$8.20. Despite 4% traffic growth, shopping behaviors reflect a stressed customer base.

2 minute read

Moderna’s Scores FDA Approval For Its Second Product – Respiratory Syncytial Virus Vaccine

By Vandana Singh

May 31, 1:16 PM

FDA approves Moderna's mRESVIA (mRNA-1345), an mRNA vaccine for RSV, for adults 60+. The second approved mRNA product from Moderna.

MRNA